drugset / Trial / NCT01921946

To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

NCT01921946

Non-randomizedCrossoverOpen-label

Summary

A phase Ⅰ study to evaluate the pharmacokinetic interactions and safety between fimasartan and rosuvastatin in healthy male volunteers.

Timeline

Start
2013-08
Primary completion
2013-09
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fimasartan Small molecule
Subject Rosuvastatin Small molecule

Indications